Sofosbuvir,velpatasvir

Form: Tablet

Strength: Sofosbuvir 400 mg + Velpatasvir 100 mg

Reference Brands: Epclusa® (EU & US)

Category: Hepatitis

Sofosbuvir and Velpatasvir tablets are a potent, once-daily fixed-dose combination used for treating chronic Hepatitis C virus (HCV) infection across all major genotypes (1-6). Sofosbuvir, an NS5B polymerase inhibitor, combined with Velpatasvir, an NS5A inhibitor, effectively blocks viral replication and assembly. Available as oral tablets containing 400 mg Sofosbuvir and 100 mg Velpatasvir, these medications are manufactured under EU-GMP and USFDA standards, ensuring high quality and safety. Widely used in hospital tenders, B2B supply, and licensing, this therapy supports rapid market registration and global distribution.